Letters to the Editor

Institute of Medicine. Clinical practice guidelines: Directions for a new program. Washington (DC): National Academy Press; 1990.

Working Group for the Canadian Psychiatric Association and Canadian Alliance for Research on Schizophrenia. Canadian clinical practice guidelines for the treatment of schizophrenia. Can J Psychiatry 1998;43 Suppl 2:25S–43S.

Hayward RSA Tunis SR Wilson MC Bass EB Rubin HR Haynes RB . More informative abstracts of articles describing clinical practice guidelines. Ann Intern Med 1993;118:731–7.

Hayward RSA Wilson MC Tunis SR Bass EB , Guyatt G; for the Evidence-Based Medicine Working Group. User's guides to the medical literature. VIII. How to use clinical practice guidelines. A Are the recommendations valid? JAMA 1995;274:570–4.

Herz NU Liberman RP Lieberman JA Marder SR McGlashan TH , Wyatt RJ, and others. Practice guidelines for the treatment of patients with schizophrenia. Am J Psychiatry 1997:154 Suppl 4.

Remington G Kapur S Zipursky RB . Pharmacotherapy of first-episode schizophrenia. Br J Psychiatry 1998;172(33 Suppl):66–70.

Jadad AR Cook DJ Jones A Klassen TP Tugwell P , Moher M, and others. Methodology and reports of systematic reviews and meta-analyses. A comparison of Cochrane Reviews with articles published in paper-based journals. JAMA 1998;280:278–80.

Srisurapanont M Disayavanish C Taimkaew K . Quetiapine for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 3, 1998. Oxford: Update Software.

Kennedy E Song F Hunter R Gilbody S . Risperidone versus ‘conventional’ antipsychotic medication for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 3, 1998. Oxford: Update Software.

Fenton M Coutinho E Campbell C . Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses (Cochrane Review). In: The Cochrane Library, Issue 3, 1998. Oxford: Update Software.

Working Group for the Canadian Psychiatric Association and Canadian Alliance for Research on Schizophrenia. Canadian clinical practice guidelines for the treatment of schizophrenia. Can J Psychiatry 1998:43 Suppl 2:25S.

Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979;121:1193–254.

Guyatt GH Sackett DL Sinclair JC Hayward R Cook DJ , Cook RJ; for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. IX. A method for grading health care recommendations. JAMA 1995;274:1800–1804.

Eddy DM . Clinical decision making: From theory to practice. Guidelines for policy statements: The explicit approach. JAMA 1990;263:2239–43.

Working Group for the Canadian Psychiatric Association and Canadian Alliance for Research on Schizophrenia. Canadian Clinical Practice Guidelines for the treatment of schizophrenia Can J Psychiatry 1998;43 Suppl 2:25S–43S.

Herz ML Liberman RP Lieberman JA Marder SR McGlashan TH , Wyatt RJ, and others. Practice guidelines for the treatment of patients with schizophrenia. Am J Psychiatry 1997;154 Suppl 4.

Remington G Kapur S Zipursky RB . Pharmacotherapy of first-episode schizophrenia. Br J Psychiatry 1998;172(33 Suppl):66–70.

Wilson JD Foster DW , editors. Williams textbook of endocrinology. 8th ed. Philadelphia: WB Saunders; 1992.

Gangull R Brar JS Rabin BS . Immune abnormalities in schizophrenia: Evidence for the autoimmune hypothesis. Harv Rev Psychiatry 1994;2 Suppl 2: 70–83.

Ganguli R Brar JS Chengappa KNR Yang ZW Nimgaonkar VL Rabin BS . Autoimmunity in schizophrenia: A review of recent findings. Ann Med 1993;25(5 Suppl):489–96.

Allen AJ Leonard HL Swedo SE . Case study: A new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995;34 Suppl 3: 307–11.

Levine J Susnovski M Handzel Z Leykin 1 Shinitzky M . Treatment of schizophrenia with an immunosuppressant. Lancet 1994;344:59–60.

Melamed Y Levy A Szor H . Between “transparent room” and “sealed room.” Professional confidentiality and therapeutic judgment. Harefuah 1997;132:457–8.

McConnell T . Confidentiality and the law. J Med Ethics 1994;20:47–9.

Greenberg D . Editorial. Isr J Psychiatry Relat Sci 1992;29:133–4.

Melamed Y Shnit D Kimchi R Elizur A . Informed consent according to the Law Regarding Treatment of the Mentally Ill (1991) compared to the Patient Rights Law (1996). Harefuah 1998;134:38–40.

Appelbaum PS Grisso T . Constructing competence: Formulating standards of legal competence to make medical decisions. Rutgers Law Review 1996;48:345–96.

Melamed Y Kimchi R Shnit D Moldavski D Elizur A . Clinical assessment of competency to consent to psychiatric hospitalization. Int J Law Psychiatry 1999;22:55–64.

Spar JE La Rue A . Concise guide to geriatric psychiatry. 2nd ed. Washington (DC): American Psychiatric Press; 1997.

Gates GA Karzon RK Garcia P Peterein J Storandt M Morris JC Miller JP . Auditory dysfunction in aging and senile dementia of the Alzheimer's type. Arch Neurol 1995;52:626–34.

Knutson JF Lansing CR . The relationship between communication problems and psychological difficulties in persons with profound acquired hearing loss. Journal of Speech & Hearing Disorders 1990;55:656–64.

Elie M Cole MG Primeau FJ Bellavance F . Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998;13:204–12.

McEwen E Anton-Culver H . The medical communication of deaf patients. J Fam Pract 1988;26:289–91.

Mulley GP Ng KY . Problems encountered by hearing-impaired people in hospitals. Lancet 1995;345:1640.

Ralston E Zadove P Gorenflo DW . Communicating with deaf patients. JAMA 1995;274:794.

Ebert DA Heckerling PS . Communication with deaf patients. Knowledge, beliefs, and practices of physicians. JAMA 1995;273:227–9.

O'Reilly RL . Mental health legislation and the right to appropriate treatment. Can J Psychiatry 1998;43:811–5.

Ontario Mental Health Act, R.S.O. 1990, c.M.7.

Mental Health Act, R.S.B.C. 1996, c.288 as amended by Bill 22, 1998(not yet in force).

Mental Health Services Act S.S. 1984–85,c.M-13.1 as amended by 1993, c. 59

Winder v. Ministry of Attorney General and Riverview Hospital July 5, 1993 No. A932127 Vancouver Registry, British Columbia Supreme Court.

Sevels v. Cameron and the Mental Health Centre, Penetanguishine , Ontarion (Ont. Ct. (Gen. Div.)) 1994 O.J. No. 2123

Mental Health Act, R.S.M. c.M.110 as amended in 1998 (not yet in force).

Pankratz WJ . The position of the Canadian Psychiatric Association on mental health legislation. Can J Psychiatry 1988;33:859–60.

Calabrese JR Fatemi SH Woyshville MJ . Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [letter]. Am J Psychiatry 1996;153:1236.

Calabrese JR Fatemi SH Kujawa M Woyshville MJ . Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996;16 Suppl 1: 24S–31S.

Fatemi SH, and others. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58:522–7.

Stein DJ, and others. Neurobiology of impulsivity and the impulse control disorders. J Neuropsychiatry Clin Neurosci 1993;5:9–17.

Lees G Leach MS . Studies on the mechanism of action of the novel anticonvulsant Lamotrigine using primary neurological cultures from rat cortex. Brain Res 1993;612:190–9.

Lieberman JA Kane JM Johns CA . Clozapine: Guidelines for clinical management. J Clin Psychiatry 1989;50:329–38.

Lilleng P Morild I Hope M . Clozapine and myocarditis. Tidsskr Nor Laegeforen 1995;115(24):3026–7.